TROG Cancer Research
Members Login   CQMS Login

Message from the TROG President

Dr Giuseppe Sasso MD FRANZCR

   
 
One in three people is touched by cancer in Australasia and over 50 percent of cancer patients will be treated with radiation therapy.  At TROG Cancer Research we do our best to improve the lives of cancer patients by conducting high quality clinical research with a focus on radiation therapy for cancers of all types. 
 
TROG Cancer Research is proud to be the largest radiation therapy clinical trial group in Australia and New Zealand. Over the past three decades almost 15,000 patients have been enrolled into our clinical trials. Thanks to over 100 clinical trials being completed, we are constantly changing and improving the way cancer is treated with radiation therapy worldwide. 
 
Our organisation consists of more than 1400 members and is made up of an extensive network of cancer specialist doctors, nurses, radiation therapists, physicists, data experts and others conducting research across a wide range of cancers. 
 
TROG is committed to promoting high quality cancer research, addressing scientific questions that matter to our people and conducting cancer research trials in every radiation therapy service in Australasia. We believe that clinical research is key to improving cancer care results and that patients enrolled in clinical trials have far better outcomes.  
 
Our mission is to help cancer patients and their families and friends, to assist cancer care professionals and hospitals where radiation therapy is delivered, and to enhance knowledge and improve skills.  We welcome your support! 
 
TROG Cancer Research is a not-for-profit company limited by guarantee. We actively engage and collaborate with other national and international Co-operative Trials Groups, government and regulatory authorities and support groups.  In 2013 we were the recipients of the NSW Premier’s award for “Innovation in Cancer Clinical Trials”.  
 
Please continue to view our website and follow up on social media for more information. 

 
 
 
 
 
 
 

We are thankful to our 14,500 patients who have participated in our research. Please continue the generous support.